checkAd
    Startseite > Aktien > ACELYRIN > Nachrichten
    ACELYRIN Aktie
    4,6800
     
    USD
    -4,10 %
    -0,2000 USD
    Letzter Kurs 11.05.24 Nasdaq
    4,6800
     
    USD
    1.500 STK
    Geldkurs 10.05.24
    4,6900
     
    USD
    1.600 STK
    Briefkurs 10.05.24
    ISIN: US00445A1007 · WKN: A3EDH4 · SYM: SLRN · USA

    Neueste Nachrichten

    ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
    09.05.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Announces Leadership Transition
    09.05.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
    29.04.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
    28.03.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease
    20.03.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
    11.03.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients
    11.03.24 · globenewswire · ACELYRIN
    ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications
    15.02.24 · globenewswire · ACELYRIN
    Final Deadline Approaching for SLRN Investors: Kessler Topaz Meltzer & Check, LLP Reminds Acelyrin, Inc. (SLRN) Investors of Class Action Lawsuit Deadline on January 16, 2024
    08.01.24 · Business Wire (engl.) · ACELYRIN
    ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
    20.12.23 · globenewswire · ACELYRIN
    SLRN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    02.12.23 · Business Wire (engl.) · ACELYRIN
    SLRN Investor Announcement: Kessler Topaz Meltzer & Check, LLP Announces January 16, 2024 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Acelyrin, Inc. (SLRN)
    01.12.23 · Business Wire (engl.) · ACELYRIN